XLVState Street Health Care Select Sector SPDR ETF
Tracks the price and yield performance of the Health Care Select Sector Index.
By State Street Investment Management · Launched 1998
Annual Cost
0.08%
#275 of 5,853 · low cost
Fund Size
$40.6B
#87 of 5,853 · large
Return (1Y)Goal
+23.2%
Track Record
27 years
#54 of 5,853 · established
Performance
Total-return NAV · USDGrowth of $10,000
$11,974+19.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Large
Strategy
Index tracking
Sector
Health careFocus
Biotech & Genomics
Index tracked
Health Care Select Sector Index
What it actually holds
By weightConcentration
Top 10 holdings = 59.1% of fundmoderately concentrated
Eli Lilly & Co
13.7%
Johnson & Johnson
11.1%
AbbVie Inc
7.2%
Merck & Co Inc
5.6%
UnitedHealth Group Inc
4.6%
Amgen Inc
3.6%
Thermo Fisher Scientific Inc
3.5%
Abbott Laboratories
3.4%
Gilead Sciences Inc
3.3%
Intuitive Surgical Inc
3.1%
Asset allocation
Stocks
99.8%
Cash
0.3%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
15.9%Moderate
Year-on-year price swings
Max drawdown
-28.4%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.35Below average
Sortino (3Y)
0.51Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Tracks the price and yield performance of the Health Care Select Sector Index.
- Strategy
- Invests in substantially all publicly traded equity securities in the Health Care Select Sector Index using a replication strategy. Covers pharmaceuticals, health care equipment, biotechnology, and health care technology.
- Inception date
- December 16, 1998
- Fund family
- State Street Investment Management
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at XLV. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-02